Bolt Biotherapeutics Inc (BOLT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -63,118 | -69,197 | -88,098 | -98,591 | -60,728 |
| Depreciation Amortization | -834 | -2,639 | 1,850 | 3,847 | 645 |
| Other Working Capital | -4,883 | -3,413 | 2,768 | 6,676 | 2,882 |
| Other Operating Activity | 7,546 | 5,724 | 6,976 | 31,002 | 9,893 |
| Operating Cash Flow | $-61,289 | $-69,525 | $-76,504 | $-57,066 | $-47,308 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 57,469 | 71,244 | 59,815 | -229,863 | -17,330 |
| PPE Investments | 107 | -206 | -1,953 | -2,338 | -3,262 |
| Investing Cash Flow | $57,576 | $71,038 | $57,862 | $-232,201 | $-20,592 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 108 | 253 | 503 | 14,890 | 294 |
| Other Financing Activity | 0 | 0 | 0 | 296,218 | 39,303 |
| Financing Cash Flow | $108 | $253 | $503 | $311,108 | $39,597 |
| Beginning Cash Position | 12,575 | 10,809 | 28,948 | 7,107 | 35,410 |
| End Cash Position | 8,970 | 12,575 | 10,809 | 28,948 | 7,107 |
| Net Cash Flow | $-3,605 | $1,766 | $-18,139 | $21,841 | $-28,303 |
| Free Cash Flow | |||||
| Operating Cash Flow | -61,289 | -69,525 | -76,504 | -57,066 | -47,308 |
| Capital Expenditure | -41 | -206 | -1,953 | -2,338 | -3,262 |
| Free Cash Flow | -61,330 | -69,731 | -78,457 | -59,404 | -50,570 |